Age-related eye disease and gender

Maturitas

Volumn 83, Issue , 2016, Pages 19-26

  Zetterberg, Madeleine ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age related macular degeneration; Aging; Blindness; Cataract; Diabetic retinopathy; Estrogen; Eye disease; Gender; Glaucoma; Visual impairment

Indexed keywords

ESTRADIOL; ESTROGEN; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN ANTIBODY;

AGE RELATED MACULAR DEGENERATION; BLINDNESS; CATARACT; CLOSED ANGLE GLAUCOMA; DIABETIC RETINOPATHY; DRUSEN; EYE DISEASE; FEMALE; GERIATRIC DISORDER; GLAUCOMA; HEALTH CARE ACCESS; HORMONE SUBSTITUTION; HUMAN; OPEN ANGLE GLAUCOMA; PSEUDOEXFOLIATION; REVIEW; SENILE CATARACT; SEX DIFFERENCE; VISUAL IMPAIRMENT; AGE; EYE DISEASES; MACULAR DEGENERATION; MALE; MENOPAUSE; PREVALENCE;

AGE FACTORS; BLINDNESS; CATARACT; DIABETIC RETINOPATHY; EYE DISEASES; FEMALE; GLAUCOMA; HUMANS; MACULAR DEGENERATION; MALE; MENOPAUSE; PREVALENCE; SEX FACTORS;

EID: 84952637971     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.10.005     Document Type: Review

References (120)

1. R. Klein, and B.E. Klein The prevalence of age-related eye diseases and visual impairment in aging: current estimates Invest. Ophthalmol. Vis. Sci. 54 14 2013 ORSF5 ORSF13
2. G.A. Stevens, R.A. White, S.R. Flaxman, H. Price, J.B. Jonas, J. Keeffe, J. Leasher, K. Naidoo, K. Pesudovs, S. Resnikoff, H. Taylor, and R.R. Bourne Vision Loss Expert G. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010 Ophthalmology 120 12 2013 2377 2384
3. A.P. Moller, C.L. Fincher, and R. Thornhill Why men have shorter lives than women: effects of resource availability, infectious disease, and senescence Am. J. Hum. Biol. 21 3 2009 357 364
4. S.N. Austad Why women live longer than men: sex differences in longevity Gend. Med. 3 2 2006 79 92
5. J.A. Yonker, V. Chang, N.S. Roetker, T.S. Hauser, R.M. Hauser, and C.S. Atwood Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity Age (Dordr.) 35 1 2013 129 138
6. J.B. Hamilton, and G.E. Mestler Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population J. Gerontol. 24 4 1969 395 411
7. C. Vitale, M. Fini, G. Speziale, and S. Chierchia Gender differences in the cardiovascular effects of sex hormones Fundam. Clin. Pharmacol. 24 6 2010 675 685
8. L.L. Yanes, and J.F. Reckelhoff Postmenopausal hypertension Am. J. Hypertens. 24 7 2011 740 749
9. M. Zetterberg, and D. Celojevic Gender and cataract - the role of estrogen Curr. Eye Res. 40 2 2015 176 190
10. D. Pascolini, and S.P. Mariotti Global estimates of visual impairment: 2010 Br. J. Ophthalmol. 96 5 2012 614 618
11. I. Abou-Gareeb, S. Lewallen, K. Bassett, and P. Courtright Gender and blindness: a meta-analysis of population-based prevalence surveys Ophthalmic Epidemiol. 8 1 2001 39 56
12. H.A. Kahn, H.M. Leibowitz, J.P. Ganley, M.M. Kini, T. Colton, R.S. Nickerson, and T.R. Dawber The Framingham Eye Study. I. Outline and major prevalence findings Am. J. Epidemiol. 106 1 1977 17 32
13. B.E. Klein, R. Klein, and K.L. Linton Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study Ophthalmology 99 4 1992 546 552
14. M. Lundstrom, U. Stenevi, and W. Thorburn Gender and cataract surgery in Sweden 1992-1997. A retrospective observational study based on the Swedish National Cataract Register Acta Ophthalmol. Scand. 77 2 1999 204 208
15. M. Lundstrom, U. Stenevi, and W. Thorburn The Swedish National Cataract Register: a 9-year review Acta Ophthalmol. Scand. 80 3 2002 248 257
16. P. Mitchell, R.G. Cumming, K. Attebo, and J. Panchapakesan Prevalence of cataract in Australia: the Blue Mountains Eye Study Ophthalmology 104 4 1997 581 588
17. J.S. Zhang, L. Xu, Y.X. Wang, Q.S. You, J.D. Wang, and J.B. Jonas Five-year incidence of age-related cataract and cataract surgery in the adult population of greater Beijing: the Beijing Eye Study Ophthalmology 118 4 2011 711 718
18. C.J. Hammond, D.D. Duncan, H. Snieder, M. de Lange, S.K. West, T.D. Spector, and C.E. Gilbert The heritability of age-related cortical cataract: the twin eye study Invest. Ophthalmol. Vis. Sci. 42 3 2001 601 605
19. C.J. Hammond, H. Snieder, T.D. Spector, and C.E. Gilbert Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins N. Engl. J. Med. 342 24 2000 1786 1790
20. B.E. Lindblad, N. Hakansson, H. Svensson, B. Philipson, and A. Wolk Intensity of smoking and smoking cessation in relation to risk of cataract extraction: a prospective study of women Am. J. Epidemiol. 162 1 2005 73 79
21. H.R. Taylor, S.K. West, F.S. Rosenthal, B. Munoz, H.S. Newland, H. Abbey, and E.A. Emmett Effect of ultraviolet radiation on cataract formation N. Engl. J. Med. 319 22 1988 1429 1433
22. D.C. Beebe, N.M. Holekamp, and Y.B. Shui Oxidative damage and the prevention of age-related cataracts Ophthalmic. Res. 44 3 2010 155 165
23. A. Ostberg, A. Loth, D. Gustafson, and B. Lindblom Skovde cataract study: I: Prevalence of lens opacities in a Swedish community Ophthalmology 113 6 2006 970 975
24. E.E. Freeman, B. Munoz, O.D. Schein, and S.K. West Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project Arch. Ophthalmol. 119 11 2001 1687 1692
25. B.E. Klein Lens opacities in women in Beaver Dam, wisconsin: is there evidence of an effect of sex hormones Trans. Am. Ophthalmol. Soc. 91 1993 517 544
26. B.E. Klein, R. Klein, and L.L. Ritter Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study Arch. Ophthalmol. 112 1 1994 85 91
27. C. Younan, P. Mitchell, R.G. Cumming, J. Panchapakesan, E. Rochtchina, and A.M. Hales Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study Am. J. Epidemiol. 155 11 2002 997 1006
28. E. Barrett-Connor, J.E. Mueller, D.G. von Muhlen, G.A. Laughlin, D.L. Schneider, and D.J. Sartoris Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study J. Clin. Endocrinol. Metab. 85 1 2000 219 223
29. D. Celojevic, A. Petersen, J.O. Karlsson, A. Behndig, and M. Zetterberg Effects of 17beta-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cells Mol. Vis. 17 2011 1987 1996
30. X. Wang, J.W. Simpkins, J.A. Dykens, and P.R. Cammarata Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability Invest. Ophthalmol. Vis. Sci. 44 5 2003 2067 2075
31. Vision. 2020. Right to sight. Blindness and visual impairment: Global facts. cited 2015. Available from: http://www.iapb.org/vision-2020/global-facts.
32. R.R. Bourne, J.B. Jonas, S.R. Flaxman, J. Keeffe, J. Leasher, K. Naidoo, M.B. Parodi, K. Pesudovs, H. Price, R.A. White, T.Y. Wong, S. Resnikoff, and H.R. Taylor Vision Loss Expert Group of the Global Burden of Disease S. Prevalence and causes of vision loss in high-in come countries and in eastern and central europe: 1990-2010 Br. J. Ophthalmol. 98 5 2014 629 638
33. N. Congdon, B. O'Colmain, C.C. Klaver, R. Klein, B. Munoz, D.S. Friedman, J. Kempen, H.R. Taylor, P. Mitchell, and Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States Arch. Ophthalmol. 122 4 2004 477 485
34. J. Ambati, B.K. Ambati, S.H. Yoo, S. Ianchulev, and A.P. Adamis Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies Surv. Ophthalmol. 48 3 2003 257 293
35. U. Schmidt-Erfurth, V. Chong, A. Loewenstein, M. Larsen, E. Souied, R. Schlingemann, B. Eldem, J. Mones, G. Richard, and F. Bandello European Society of Retina S. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br. J. Ophthalmol. 98 9 2014 1144 1167
36. Age-Related Eye Disease Study Research Group Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3 Ophthalmology 107 12 2000 2224 2232
37. H. Buch, N.V. Nielsen, T. Vinding, G.B. Jensen, J.U. Prause, and M. la Cour 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study Ophthalmology 112 5 2005 787 798
38. A. Laitinen, L. Laatikainen, T. Harkanen, S. Koskinen, A. Reunanen, and A. Aromaa Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey Acta Ophthalmol. 88 4 2010 463 471
39. U. Chakravarthy, T.Y. Wong, A. Fletcher, E. Piault, C. Evans, G. Zlateva, R. Buggage, A. Pleil, and P. Mitchell Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis BMC Ophthalmol. 10 2010 31
40. W. Smith, P. Mitchell, and J.J. Wang Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study Aust. N. Z. J. Ophthalmol. 25 Suppl. 1 1997 13 15
41. A.R. Rudnicka, Z. Jarrar, R. Wormald, D.G. Cook, A. Fletcher, and C.G. Owen Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis Ophthalmology 119 3 2012 571 580
42. K.K. Snow, J. Cote, W. Yang, N.J. Davis, and J.M. Seddon Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women Am. J. Ophthalmol. 134 6 2002 842 848
43. R. Defay, S. Pinchinat, S. Lumbroso, C. Sutan, C. Delcourt, and Pola Study Group Sex steroids and age-related macular degeneration in older French women: the POLA study Ann. Epidemiol. 14 3 2004 202 208
44. J. Blasiak, G. Petrovski, Z. Vereb, A. Facsko, and K. Kaarniranta Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration BioMed Res. Int. 2014 2014 768026
45. K. Kaarniranta, A. Machalinska, Z. Vereb, A. Salminen, G. Petrovski, and A. Kauppinen Estrogen signalling in the pathogenesis of age-related macular degeneration Curr. Eye Res. 40 2 2015 226 233
46. D.J. Calkins Critical pathogenic events underlying progression of neurodegeneration in glaucoma Prog. Retin. Eye Res. 31 6 2012 702 719
47. Y.C. Tham, X. Li, T.Y. Wong, H.A. Quigley, T. Aung, and C.Y. Cheng Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis Ophthalmology 121 11 2014 2081 2090
48. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 90 3 2006 262 267
49. A.R. Rudnicka, S. Mt-Isa, C.G. Owen, D.G. Cook, and D. Ashby Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis Invest. Ophthalmol. Vis. Sci. 47 10 2006 4254 4261
50. S. Tehrani Gender difference in the pathophysiology and treatment of glaucoma Curr. Eye Res. 40 2 2015 191 200
51. S. Senthil, C. Garudadri, R.C. Khanna, and K. Sannapaneni Angle closure in the Andhra Pradesh eye disease study Ophthalmology 117 9 2010 1729 1735
52. W. Song, L. Shan, F. Cheng, P. Fan, L. Zhang, W. Qu, Q. Zhang, and H. Yuan Prevalence of glaucoma in a rural northern china adult population: a population-based survey in kailu county, inner mongolia Ophthalmology 118 10 2011 1982 1988
53. S.K. Seah, P.J. Foster, P.T. Chew, A. Jap, F. Oen, H.B. Fam, and A.S. Lim Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey Arch. Ophthalmol. 115 11 1997 1436 1440
54. P.H. Alsbirk Anatomical risk factors in primary angle-closure glaucoma. A ten year follow up survey based on limbal and axial anterior chamber depths in a high risk population Int. Ophthalmol. 16 4-5 1992 265 272
55. J.C. Erie, D.O. Hodge, and D.T. Gray The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota Arch. Ophthalmol. 115 2 1997 177 181
56. W.S. Ng, G.S. Ang, and A. Azuara-Blanco Primary angle closure glaucoma: a descriptive study in Scottish Caucasians Clin. Exp. Ophthalmol. 36 9 2008 847 851
57. T.D. Keenan, R. Goldacre, and M.J. Goldacre Associations between primary open angle glaucoma, Alzheimer's disease and vascular dementia: record linkage study Br. J. Ophthalmol. 99 4 2015 524 527
58. D. Moore, A. Harris, D. Wudunn, N. Kheradiya, and B. Siesky Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma? Clin. Ophthalmol. 2 4 2008 849 861
59. F. Jonasson From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland Acta Ophthalmol. 87 5 2009 478 487
60. A. Arnarsson, H. Sasaki, and F. Jonasson Twelve-year incidence of exfoliation syndrome in the Reykjavik Eye Study Acta Ophthalmol. 91 2 2013 157 162
61. S. Astrom, H. Stenlund, and C. Linden Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up Acta Ophthalmol. Scand. 85 8 2007 832 837
62. J.H. Kang, S. Loomis, J.L. Wiggs, J.D. Stein, and L.R. Pasquale Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts Ophthalmology 119 1 2012 27 35
63. G. Thorleifsson, K.P. Magnusson, P. Sulem, G.B. Walters, D.F. Gudbjartsson, H. Stefansson, T. Jonsson, A. Jonasdottir, A. Jonasdottir, G. Stefansdottir, G. Masson, G.A. Hardarson, H. Petursson, A. Arnarsson, M. Motallebipour, O. Wallerman, C. Wadelius, J.R. Gulcher, U. Thorsteinsdottir, A. Kong, F. Jonasson, and K. Stefansson Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma Science 317 5843 2007 1397 1400
64. J.H. Kang, J.L. Wiggs, and L.R. Pasquale Relation between time spent outdoors and exfoliation glaucoma or exfoliation glaucoma suspect Am. J. Ophthalmol. 158 3 2014 605 614 e601
65. H.G. Scheie, and J.D. Cameron Pigment dispersion syndrome: a clinical study Br. J. Ophthalmol. 65 4 1981 264 269
66. W.E. Gillies, and A.M. Brooks Clinical features at presentation of anterior segment pigment dispersion syndrome Clin. Exp. Ophthalmol. 29 3 2001 125 127
67. A.J. Lee, P. Mitchell, E. Rochtchina, P.R. Healey, and S. Blue Mountains Eye Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study Br. J. Ophthalmol. 87 11 2003 1324 1328
68. L.R. Pasquale, B.A. Rosner, S.E. Hankinson, and J.H. Kang Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study J. Glaucoma 16 7 2007 598 605
69. J.A. Ebeigbe, P.N. Ebeigbe, and A. Ighoroje Ocular changes in pregnant Nigerian women Niger. J. Clin. Pract. 15 3 2012 298 301
70. I.A. Qureshi Measurements of intraocular pressure throughout the pregnancy in Pakistani women Chin. Med. Sci. J. 12 1 1997 53 56
71. K.S. Na, D.H. Jee, K. Han, Y.G. Park, M.S. Kim, and E.C. Kim The ocular benefits of estrogen replacement therapy: a population-based study in postmenopausal Korean women PLoS One 9 9 2014 e106473
72. N.L. Tint, P. Alexander, K.M. Tint, G.T. Vasileiadis, A.M. Yeung, and A. Azuara-Blanco Hormone therapy and intraocular pressure in nonglaucomatous eyes Menopause 17 1 2010 157 160
73. P.A. Newman-Casey, N. Talwar, B. Nan, D.C. Musch, L.R. Pasquale, and J.D. Stein The potential association between postmenopausal hormone use and primary open-angle glaucoma JAMA Ophthalmol. 132 3 2014 298 303
74. L.R. Pasquale, and J.H. Kang Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study Eye (Lond.) 25 5 2011 633 641
75. M.A. Arevalo, I. Azcoitia, and L.M. Garcia-Segura The neuroprotective actions of oestradiol and oestrogen receptors Nat. Rev. Neurosci. 16 1 2015 17 29
76. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 9735 2010 124 136
77. ETDRS Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early treatment diabetic retinopathy study research group Arch. Ophthalmol. 103 12 1985 1796 1806
78. G. Virgili, M. Parravano, F. Menchini, and J.R. Evans Anti-vascular endothelial growth factor for diabetic macular oedema Cochrane Database Syst. Rev. 10 2014 PubMed CD007419
79. P.E. Wandell, and A.C. Carlsson Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden Curr. Diabetes Rev. 9 4 2013 342 349
80. H.P. Hammes, W. Kerner, S. Hofer, O. Kordonouri, K. Raile, R.W. Holl, and D.P.-W.S. Group Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8784 patients Diabetologia 54 8 2011 1977 1984
81. M.S. Roy, R. Klein, B.J. O'Colmain, B.E. Klein, S.E. Moss, and J.H. Kempen The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States Arch. Ophthalmol. 122 4 2004 546 551
82. N. Chaturvedi, A.K. Sjoelie, M. Porta, S.J. Aldington, J.H. Fuller, M. Songini, and E.M. Kohner Study E.P.C. markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes Diabetes Care 24 2 2001 284 289
83. R. Klein, M.D. Knudtson, K.E. Lee, R. Gangnon, and B.E. Klein The Wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes Ophthalmology 116 3 2009 497 503
84. D.S. Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts Diabetes Care 26 1 2003 61 69
85. G.Y. Ozawa, M.A. Bearse Jr., and A.J. Adams Male-female differences in diabetic retinopathy? Curr. Eye Res. 40 2 2015 234 246
86. K. Kostev, and W. Rathmann Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis Diabetologia 56 1 2013 109 111
87. H.C. Looker, S.O. Nyangoma, D. Cromie, J.A. Olson, G.P. Leese, M. Black, J. Doig, N. Lee, R.S. Lindsay, J.A. McKnight, A.D. Morris, S. Philip, N. Sattar, S.H. Wild, and H.M. Colhoun Scottish Diabetic Retinopathy Screening C, Scottish Diabetes Research Network Epidemiology G. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland Diabetologia 55 9 2012 2335 2342
88. J.E. Manson, and et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials JAMA 310 13 2013 1353 1368
89. E.D. Szmuilowicz, C.A. Stuenkel, and E.W. Seely Influence of menopause on diabetes and diabetes risk Nat. Rev. Endocrinol. 5 10 2009 553 558
90. C. Diabetes, and Complications Trial Research Group Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group Diabetes Care 23 8 2000 1084 1091
91. S. Arber, J. McKinlay, A. Adams, L. Marceau, C. Link, and A. O'Donnell Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment Soc. Sci. Med. 62 1 2006 103 115
92. A.R. Ulldemolins, V.C. Lansingh, L.G. Valencia, M.J. Carter, and K.A. Eckert Social inequalities in blindness and visual impairment: a review of social determinants Indian J. Ophthalmol. 60 5 2012 368 375
93. A. Rius, L. Artazcoz, L. Guisasola, and J. Benach Visual impairment and blindness in spanish adults: geographic inequalities are not explained by age or education Ophthalmology 121 1 2014 408 416
94. S. Lewallen, and P. Courtright Gender and use of cataract surgical services in developing countries Bull. World Health Org. 80 4 2002 300 303
95. P.K. Nirmalan, A. Padmavathi, and R.D. Thulasiraj Sex inequalities in cataract blindness burden and surgical services in south India Br. J. Ophthalmol. 87 7 2003 847 849
96. S. Lewallen, A. Mousa, K. Bassett, and P. Courtright Cataract surgical coverage remains lower in women Br. J. Ophthalmol. 93 3 2009 295 298
97. M. Khairallah, R. Kahloun, S.R. Flaxman, J.B. Jonas, J. Keeffe, J. Leasher, K. Naidoo, K. Pesudovs, H. Price, R.A. White, T.Y. Wong, S. Resnikoff, H.R. Taylor, R.R. Bourne, and Vision Loss Expert Group Prevalence and causes of vision loss in North Africa and the Middle East: 1990-2010 Br. J. Ophthalmol. 98 5 2014 605 611
98. G. Smirthwaite, M. Lundstrom, S. Albrecht, and K. Swahnberg Indication criteria for cataract extraction and gender differences in waiting time Acta Ophthalmol. 92 5 2014 432 438
99. G.L. Kanthan, J.J. Wang, G. Burlutsky, E. Rochtchina, R.G. Cumming, and P. Mitchell Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: the Blue Mountains Eye Study Acta Ophthalmol. 88 7 2010 773 778
100. K. Worzala, R. Hiller, R.D. Sperduto, K. Mutalik, J.M. Murabito, M. Moskowitz, R.B. D'Agostino, and P.W. Wilson Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies Arch. Intern. Med. 161 11 2001 1448 1454
101. B.E. Lindblad, N. Hakansson, B. Philipson, and A. Wolk Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women Ophthalmology 117 3 2010 424 430
102. R.J. Casson, D. Marshall, H.S. Newland, S. McGovern, J. Muecke, E.W. Tan, D. Selva, and T. Aung Risk factors for early angle-closure disease in a Burmese population: the Meiktila Eye Study Eye (Lond.) 23 4 2009 933 939
103. G.H. Van Rens, S.M. Arkell, W. Charlton, and W. Doesburg Primary angle-closure glaucoma among Alaskan Eskimos Doc. Ophthalmol. 70 2-3 1988 265 276
104. L. Xu, W.F. Cao, Y.X. Wang, C.X. Chen, and J.B. Jonas Anterior chamber depth and chamber angle and their associations with ocular and general parameters: the Beijing Eye Study Am. J. Ophthalmol. 145 5 2008 929 936.e1
105. P. Mitchell, W. Smith, K. Attebo, and J.J. Wang Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology 102 10 1995 1450 1460
106. J.R. Evans Risk factors for age-related macular degeneration Prog. Retin. Eye Res. 20 2 2001 227 253
107. J.R. Vingerling, I. Dielemans, J.C. Witteman, A. Hofman, D.E. Grobbee, and P.T. de Jong Macular degeneration and early menopause: a case-control study BMJ 310 6994 1995 1570 1571
108. M.G. Erke, G. Bertelsen, T. Peto, A.K. Sjolie, H. Lindekleiv, and I. Njolstad Lactation, female hormones and age-related macular degeneration: the Tromso Study Br. J. Ophthalmol. 97 8 2013 1036 1039
109. D. Feskanich, E. Cho, D.A. Schaumberg, G.A. Colditz, and S.E. Hankinson Menopausal and reproductive factors and risk of age-related macular degeneration Arch. Ophthalmol. 126 4 2008 519 524
110. S. Fraser-Bell, J. Wu, R. Klein, S.P. Azen, and R. Varma Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study Am. J. Ophthalmol. 141 1 2006 79 87
111. K. Kinnunen, G. Petrovski, M.C. Moe, A. Berta, and K. Kaarniranta Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration Acta Ophthalmol. 90 4 2012 299 309
112. C.A. McCarty, and H.R. Taylor Pseudoexfoliation syndrome in Australian adults Am. J. Ophthalmol. 129 5 2000 629 633
113. W. Wang, M. He, M. Zhou, and X. Zhang Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis PLoS One 9 3 2014 e92767
114. L.R. Pasquale, A.Z. Jiwani, T. Zehavi-Dorin, A. Majd, D.J. Rhee, T. Chen, A. Turalba, L. Shen, S. Brauner, C. Grosskreutz, M. Gardiner, S. Chen, S. Borboli-Gerogiannis, S.H. Greenstein, K. Chang, R. Ritch, S. Loomis, J.H. Kang, J.L. Wiggs, and H. Levkovitch-Verbin Solar exposure and residential geographic history in relation to exfoliation syndrome in the United States and Israel JAMA Ophthalmol. 132 12 2014 1439 1445
115. C.A. Hulsman, I.C. Westendorp, R.S. Ramrattan, R.C. Wolfs, J.C. Witteman, J.R. Vingerling, A. Hofman, and P.T. de Jong Is open-angle glaucoma associated with early menopause? The Rotterdam Study Am. J. Epidemiol. 154 2 2001 138 144
116. L.P. Doucette, A. Rasnitsyn, M. Seifi, and M.A. Walter The interactions of genes, age, and environment in glaucoma pathogenesis Surv. Ophthalmol. 60 4 2015 310 326
117. J. Caprioli, and A.L. Coleman Blood flow in Glaucoma D. Blood pressure, perfusion pressure, and glaucoma Am. J. Ophthalmol. 149 5 2010 704 712
118. X. Zhang, J.B. Saaddine, C.F. Chou, M.F. Cotch, Y.J. Cheng, L.S. Geiss, E.W. Gregg, A.L. Albright, B.E. Klein, and R. Klein Prevalence of diabetic retinopathy in the United States, 2005-2008 JAMA 304 6 2010 649 656
119. F. Semeraro, A. Cancarini, R. dell'Omo, S. Rezzola, M.R. Romano, and C. Costagliola Diabetic eetinopathy vascular and inflammatory disease J. Diabetes Res. 2015 2015 582060
120. T. Behl, I. Kaur, and A. Kotwani Implication of oxidative stress in progression of diabetic retinopathy Surv. Ophthalmol. June (11) 2015 10.1016/j.survophthal.2015.06.001 pii: S0039-6257(15)00100-9 [Epub ahead of print]